Theorem Clinical Research has announced the formation of a strategic alliance with BioTelemetry, Inc.
Theorem Clinical Research
, a clinical research organization specializing in complex trials, has announced the formation of a strategic alliance with BioTelemetry, Inc. (Nasdaq: BEAT). BioTelemetry’s Clinical Research division includes Cardiocore, a global cardiac core laboratory.
“Theorem’s business strategy is to offer our clients the very best in every service area,” said
John Potthoff
, Theorem president and CEO. “BioTelemetry reinforces that strategy with a team of industry-leading scientists, a set of advanced technologies and a broad base of cardiac testing modalities. Theorem clients will benefit from BioTelemetry’s expert consulting services and deep experience across all major therapeutic areas.”
BioTelemetry
CEO Joseph Capper noted, “Theorem’s experience in complex protocols aligns perfectly with our specialized cardiovascular testing services. The partnership complements BioTelemetry’s unique position that spans from clinical research through post-market surveillance and into clinical practice. Both companies support trials in
all clinical phases
of pharmaceutical and biotech development and will collaborate globally within this alliance.”
“Trends in the industry such as safety monitoring boards, translational medicine and risk-based monitoring put additional pressures on the clinical trial process to be faster, safer and more efficient,” said Potthoff. “Our strategic partnership with BioTelemetry allows us to meet — and exceed — those industry standards for our clients.”
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.